CompaniesArthrogen

Arthrogen

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

27

By Phase

PHASE1: 2

By Status

UNKNOWN: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT02727764
NCT03445715
Hover over trial bars to see details

Recent Trials

NCT03445715Lead Sponsor
ART-I02 in Patients With Rheumatoid Arthritis With Inflamed Wrists
PHASE1Unknown
15 participants
Started: Jan 3, 2018 · Completed: Jan 31, 2020
NCT02727764Lead Sponsor
A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis
PHASE1Unknown
12 participants
Started: Apr 20, 2017 · Completed: Sep 30, 2022